GoodRx Holdings (GDRX) Retained Earnings (2019 - 2026)

GoodRx Holdings has disclosed Retained Earnings across 8 years of filings, most recently posting -$1.4 billion for Q1 2026.

• Retained Earnings for Q1 2026 came in at -$1.4 billion, up 1.44% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.4 billion (up 1.44% YoY), and the FY2025 annual result was -$1.4 billion, up 2.11% from the prior year.
• Retained Earnings came in at -$1.4 billion for Q1 2026 at GoodRx Holdings, roughly flat from -$1.4 billion in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$1.4 billion in Q2 2023 to a low of -$1.5 billion in Q1 2024.
• The 5-year median for Retained Earnings is -$1.4 billion (2023), against an average of -$1.4 billion.
• Across the five-year window, Retained Earnings fell 5.14% in 2022 and increased 2.38% in 2025, its largest moves.
• GoodRx Holdings' Retained Earnings stood at -$1.4 billion in 2022, then dropped by 0.61% to -$1.5 billion in 2023, then grew by 1.12% to -$1.4 billion in 2024, then climbed by 2.11% to -$1.4 billion in 2025, then advanced by 0.08% to -$1.4 billion in 2026.
• The last three Retained Earnings figures came in at -$1.4 billion (Q1 2026), -$1.4 billion (Q4 2025), and -$1.4 billion (Q3 2025), per Business Quant data.